Sodium‐glucose co‐transporter 2 inhibitors in acute heart failure: real‐world prescription trends and outcomes analysis

Sodium‐glucose co‐transporter 2 inhibitors in acute heart failure: real‐world prescription trends and outcomes analysis

Abstract Aims Sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have shown potential therapeutic benefits in heart failure (HF). However, data on their real‐world usage and benefits in acute decompensated heart failure (ADHF) are limited. Methods and results We conducted a post hoc analysis of real...

Full description

Bibliographic Details
Main Authors: Saki Mizobuchi, Yuki Saito, Daisuke Kitano, Kazuto Toyama, Masatsugu Miyagawa, Yutaka Koyama, Hidesato Fujito, Keisuke Kojima, Nobuhiro Murata, Daisuke Fukamachi, Yasuo Okumura
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:ESC Heart Failure
Subjects:
Acute heart failure
Prognosis
Prescription trends
Sodium‐glucose co‐transporter 2 inhibitors
Online Access:https://doi.org/10.1002/ehf2.14597

Internet

https://doi.org/10.1002/ehf2.14597

Similar Items